DAM-57
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (6aR,9R)-N,N-dimethyl-7-methyl-4,6,6a,7,8,9- |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Controlled in the US via the Federal Analog Act but only if it is intended for human consumption. |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 199478 |
| ChemSpider | 172668  |
| Synonyms | DAM-57, Lysergic acid dimethylamide |
| Chemical data | |
| Formula | C18H21N3O |
| Mol. mass | 295.39 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
N,N-Dimethyllysergamide (DAM-57) is a derivative of ergine.
It may cause LSD-like effects at doses of 1 milligram or more but this is disputed.
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
